| 1 | Bezafibrate (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 7件:  20 20, 93, 94, 160, 296, 316, 324 | 
| 2 | Bezafibrate (400mg) in addition to standard 15-20 mg/kg/jour UDCA therapy (Synonym: D01366) | 2件:  Bezafibrate Bezafibrate, Ursodeoxycholic acid | 2件:  D00734 
                
                    D00734
                
            , 
                
                    D01366
                
             | 2件:  NR1H4 NR1H4, PPARA 💬 | 11件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  94 94 | 
| 3 | Bezafibrate (drug) (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  316 316 | 
| 4 | Bezafibrate (INN 3968) (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  324 324 | 
| 5 | Bezafibrate 100 MG (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 | 
| 6 | Bezafibrate 200 MG (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 | 
| 7 | Bezafibrate 200 MG Oral Tablet (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 | 
| 8 | Bezafibrate 400 MG (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 | 
| 9 | Bezafibrate IR (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 | 
| 10 | Bezafibrate SR (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 | 
| 11 | Bezafibrate, Beza, BZF, Bezalip (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 | 
| 12 | Bezafibrate, Beza, BZF, Bezalip mono (Synonym: D01366) | 1件:  Bezafibrate Bezafibrate | 1件:  D01366 
                
                    D01366
                
             | 1件:  PPARA PPARA 💬 | 10件:  Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | 1件:  93 93 |